Tattoo Numbing Cream Co. sold Signature Tattoo Numbing Cream and Miracle Numb Spray as unapproved drugs for tattooing.
What happened
FDA reviewed the company's website in November 2023 and found Signature Tattoo Numbing Cream and Miracle Numb Spray offered for sale and marketed for numbing before or during tattooing. FDA said the products list lidocaine 5%, above the 0.5% to 4% range allowed for nonprescription external pain-relief products, and include active-ingredient combinations and tattooing claims not permitted by the FDA order for those products.
What FDA found
The products are new drugs sold without an FDA-approved application and do not meet the FDA order for nonprescription external pain-relief products.
section 505(a) of the FD&C Act, 21 U.S.C. 355(a)The products are misbranded (mislabeled under the law) because they are nonprescription drugs that do not meet section 505G and have no approved application.
section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)The labels list lidocaine at 5%, which is above the 0.5% to 4% range permitted for nonprescription external pain-relief products.
Over-the-Counter Monograph M017; section 505G of the FD&C Act, 21 U.S.C. 355hThe products combine more than one “-caine” ingredient and include epinephrine, propylamine, glycerol, or purified water as active ingredients, which M017 does not permit.
Over-the-Counter Monograph M017; section 505G of the FD&C Act, 21 U.S.C. 355hThe labeling claims use for tattooing, including on broken skin, which is not an indication included in M017 or another final order.
Over-the-Counter Monograph M017; section 505G of the FD&C Act, 21 U.S.C. 355h
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt about steps taken to address the violations, including how it will prevent recurrence, and to explain any delay if correction cannot be completed in that time. If the company believes the products are not in violation, it must include its reasoning and supporting information.
Who should pay attention
- tattoo studios and artists who recommend numbing creams
- retailers and marketplaces selling topical numbing products
- brands selling nonprescription external pain-relief products
This is a summary. Read the original letter on fda.gov.